Laboratory signs of activated coagulation are common in Henoch-Schonlein purpura

被引:35
作者
Brendel-Müller, K
Hahn, A
Schneppenheim, R
Santer, R
机构
[1] Univ Kiel, Dept Paediat, D-24105 Kiel, Germany
[2] Univ Kiel, Dept Paediat Neurol, Kiel, Germany
[3] Univ Hamburg, Dept Paediat Haematol & Oncol, Hamburg, Germany
关键词
blood coagulation; haemostasis; Henoch-Schonlein purpura; hyperfibrinolysis;
D O I
10.1007/s004670100033
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We investigated 17 patients with Henoch-Schonlein purpura (HSP) and describe as yet unreported abnormal results of blood coagulation tests. In parallel to the activity of the disease, D-dimer concentrations in plasma were found to be significantly increased in 15 of the 17 patients; almost 50% of all patients showed values higher than 10 times the upper limit of the normal range. In 11 patients, plasma concentrations of thrombin-antithrombin complex (TAT) and prothrombin fragments I and 2 (F1+2) were examined; six of them showed abnormal results. The pathologic values were correlated to the activity of the disease, but abnormalities were also found in milder cases of HSP. These findings probably reflect local reactions within inflamed blood vessels rather than a systemic activation of coagulation and hyperfibrinolysis. Clinicians should be aware of these laboratory findings in order not to confuse common cases of HSP with purpura necroticans, a very severe type of vasculitis in which signs of disseminated intravascular coagulation (DIC) have been reported. Our findings suggest that an activation of coagulation including hyperfibrinolysis secondary to the endothelial damage is a typical feature of the common types of HSP.
引用
收藏
页码:1084 / 1088
页数:5
相关论文
共 7 条
  • [1] THE CLINICAL SPECTRUM OF HENOCH-SCHONLEIN PURPURA IN INFANTS AND YOUNG-CHILDREN
    ALSHEYYAB, M
    ELSHANTI, H
    AJLOUNI, S
    SAWALHA, D
    DAOUD, A
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1995, 154 (12) : 969 - 972
  • [2] FIBRIN DEPOSITS AND FIBRINOLYTIC-ACTIVITY IN SCHONLEIN-HENOCH SYNDROME
    BIANCHINI, G
    LOTTI, T
    FABBRI, P
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1983, 22 (02) : 103 - 106
  • [3] BOROS G, 1979, ACTA MED HUNG, V36, P151
  • [4] VON-WILLEBRAND-FACTOR AND FACTOR-XIII IN CHILDREN WITH HENOCH-SCHONLEIN PURPURA
    DEMATTIA, D
    PENZA, R
    GIORDANO, P
    DELVECCHIO, GC
    ACETO, G
    ALTOMARE, M
    SCHETTINI, F
    [J]. PEDIATRIC NEPHROLOGY, 1995, 9 (05) : 603 - 605
  • [5] FACTOR-XIII (FIBRIN STABILIZING FACTOR) IN HENOCH-SCHONLEINS PURPURA
    HENRIKSSON, P
    HEDNER, U
    NILSSON, IM
    [J]. ACTA PAEDIATRICA SCANDINAVICA, 1977, 66 (03): : 273 - 277
  • [6] Hergesell O, 1996, THROMB HAEMOSTASIS, V75, P892
  • [7] ACTIVITY OF BLOOD-COAGULATION FACTOR-XIII AS A PROGNOSTIC INDICATOR IN PATIENTS WITH HENOCH-SCHONLEIN PURPURA - EFFICACY OF FACTOR-XIII SUBSTITUTION
    KAMITSUJI, H
    TANI, K
    YASUI, M
    TANIGUCHI, A
    TAIRA, K
    TSUKADA, S
    IIDA, Y
    KANKI, H
    FUKUI, H
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1987, 146 (05) : 519 - 523